Recently, an increasing number of studies have implied that PCSK9 might affect CAD beyond its effects on lipids and that it also interacts with cardiovascular risk factors, such as insulin resistance13,14, inflammation15, platelet activation16, and thrombosis17. Here, PCSK9 is linked to coronary artery disorder.